|1.||Meikle, Peter J: 2 articles (01/2005 - 05/2004)|
|2.||Hopwood, John J: 2 articles (01/2005 - 05/2004)|
|3.||Fuller, Maria: 2 articles (01/2005 - 05/2004)|
|4.||Ahmad, Altaf: 1 article (01/2015)|
|5.||Yousuf, Peerzada Yasir: 1 article (01/2015)|
|6.||Iqbal, Muhammad: 1 article (01/2015)|
|7.||Aref, Ibrahim M: 1 article (01/2015)|
|8.||Ahmad, Sayeed: 1 article (01/2015)|
|9.||Ganie, Arshid Hussain: 1 article (01/2015)|
|10.||Pandey, Renu: 1 article (01/2015)|
08/01/2009 - "Here we show that monoclonal antibody 54-5C10-A, which is used to diagnose schistosomiasis in humans, interacts with oligomers of at least three Lewis X trisaccharides, but not with monomeric Lewis X. We describe the sequence and the 2.5 A crystal structure of its Fab fragment and infer a possible mode of binding of the polymeric Lewis X from docking studies. "
08/01/1998 - "Additionally, glycohistochemical features, including binding capacities for histo-blood group trisaccharides, have the potential to aid in establishment of a biologic marker set for tumor staging."
10/01/2012 - "They have been successfully used as building blocks to synthesize tailor-made di- and trisaccharides involved in the structure of lacto-N-neo-tetraose and precursors of the tumor-associated carbohydrate antigen T and the antitumoral drug peracetylated β-naphtyl-lactosamine. "
10/01/1996 - "Histochemical detection of expression of binding sites for labelled hyaluronic acid and carrier-immobilized synthetic (histo-blood group trisaccharides) or biochemically purified (ganglioside GM1) glycoligands in nasal polyps and other human lesions including neoplasms."
10/01/2002 - "Metastatic cells with low tumorogenic activity weakly expressed lectins to disaccharide ligands 6-SiaLac [Neu5Aca2-6Galb1-4Glc], 6-HSO3LacNAc, and A-di [GalNAca 1-3Galb] and trisaccharides H-type 1 [Fuca1-2Galb1-3GlcNAc and Lex [Fuca1-3(Galb 1-4)GlcNAc] compared to cells that initiated tumor formation in the syngeneic system (similarly to transplanted tumors). "
02/15/1996 - "Structural chemistry of MUC1 oligosaccharides demonstrated that the cancer-associated glycoforms carry mainly sialylated trisaccharides NeuAc alpha 2-3Gal Beta 1-3GalNAc or NeuAc alpha 2-6(Gal beta l-3)GalNAc, exhibit a concomitant decrease in the ratio of GlcNAc/GalNAc, a reduction or disappearance of L-fucose, and a partial substitution of N-acetylneuraminic acid by the N-glycolylated variant. "
|4.||Mucopolysaccharidosis I (Hurler Syndrome)
01/01/2005 - "Moreover, a ratio of alpha-l-iduronidase activity to these trisaccharides provided clear discrimination between mucopolysaccharidosis I patients with and without central nervous system pathology. "
05/01/2004 - "Cultured skin fibroblasts from mucopolysaccharidosis I patients accumulate the same dermatan sulfate-and heparan sulfate-derived di- and trisaccharides as identified in urine, and supplementation of culture medium with recombinant alpha-l-iduronidase reduced their level to that of unaffected control fibroblasts. "
03/01/2001 - "Histological sections of 43 cases of esophageal carcinomas were analyzed with labeled galectins-1 and -3 and their specific antibodies, neoglycoconjugates exposing chemically prepared histo-blood group A-, B- and H-trisaccharides and the antibody MIB-1 (Ki-67). "
01/01/1994 - "Biotinylated sarcolectin, neoglycoproteins with lactose or N-acetylglucosamine residues, and polyacrylamide-attached trisaccharides, that represent the ABH histo-blood group antigens, were applied to sections of 187 primary lung carcinomas. "
|2.||Immunoglobulin M (IgM)
|3.||N-Acetylneuraminic Acid (Sialic Acid)
|10.||Mannose-Binding Lectin (Mannan-Binding Lectin)